Promoting Weight Loss and Stress Reduction in Overweight and Obese Patients With Type 2 Diabetes
1 other identifier
interventional
58
1 country
2
Brief Summary
This is a feasibility and acceptability study of a 16-month single-blind randomized controlled trial (RCT) designed to test the initial effectiveness of a well-being and small lifestyle changes intervention aimed at promoting weight loss and stress reduction in overweight and obese patients with type 2 diabetes. Primary goals of this study are to 1) evaluate study feasibility and patient acceptability, 2) develop a tailored protocol of a behavioral intervention for overweight or obese patients with type 2 diabetes that takes stress and well-being into consideration, 3) evaluate appropriateness of research procedures and measures, 4) examine effect size estimates of key outcomes to provide essential data to inform a larger efficacy trial, 5) determine whether clinically significant improvements occurred in any key outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus-type-2
Started Mar 2018
Typical duration for not_applicable diabetes-mellitus-type-2
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 27, 2018
CompletedFirst Submitted
Initial submission to the registry
July 11, 2018
CompletedFirst Posted
Study publicly available on registry
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 18, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 18, 2020
CompletedMarch 12, 2021
March 1, 2021
2.6 years
July 11, 2018
March 11, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Feasibility (Recruitment)
Measured as the acceptance rate (total number of participants enrolled out of the total number of eligible candidates approached).
Baseline
Feasibility (Retention)
Measured as drop-out rates (total number of participants who withdraw out of the total number enrolled).
Through study completion, intended to be 16 months
Feasibility (Acceptability of Intervention)
Measured as total number of sessions attended and number of weeks needed to complete the intervention. Semi-structured interviews will be conducted to estimate patients' satisfaction and provide data on optimal timing, dosing, and delivery.
Post-intervention, intended to be 4 months
Secondary Outcomes (4)
Change in Psychological Distress
Baseline, post-intervention (intended to be 4 months), 6 months post-intervention, 12 months post-intervention
Change in Psychological Distress and Well-Being
Baseline, post-intervention (intended to be 4 months), 6 months post-intervention, 12 months post-intervention
Change in Psychological Well-Being
Baseline, post-intervention (intended to be 4 months), 6 months post-intervention, 12 months post-intervention
% Weight Change
Baseline, post-intervention (intended to be 4 months), 6 months post-intervention, 12 months post-intervention
Other Outcomes (7)
Change in the Prevalence of Psychosomatic Syndromes
Baseline, post-intervention (intended to be 4 months), 6 months post-intervention, 12 months post-intervention
Change in Hemoglobin A1C
Baseline, post-intervention (intended to be 4 months), 6 months post-intervention, 12 months post-intervention
Change in Abdominal Circumference
Baseline, post-intervention (intended to be 4 months), 6 months post-intervention, 12 months post-intervention
- +4 more other outcomes
Study Arms (2)
Well-being and small change
EXPERIMENTALParticipants will be randomized to receive 4 individual 1-hour weekly sessions of the well-being intervention before starting the 12 individual 1-hour weekly sessions of the small change intervention in addition to the treatment as usual.
Small change
ACTIVE COMPARATORParticipants will be randomized to receive 12 individual 1-hour weekly sessions of the small change intervention in addition to the treatment as usual.
Interventions
The small change intervention is a behavioral intervention to help people gradually lose weight by making small changes in their lifestyle. At the beginning of the intervention participants will be met in person to be guided in setting an eating and a physical activity goal. Participants will be then contacted through the phone or met in person weekly for 3 months to check on their adherence to the selected goals and to discuss about facilitators and barriers to goal completion, in order to increase their motivation and problem solving skills. Every weekly contact will last about an hour and will be administered in an individual setting. At each contact selected goals can be revised, changed or another goal can be added based on levels of adherence.
The well-being intervention is a coaching intervention aimed at motivating people in making lifestyle changes by reducing levels of stress through the promotion of psychological well-being. It will consists in 4 weekly sessions to be held before starting the small change intervention. Each session will last about an hour and will be administered in an individual setting.
The treatment as usual includes any recommendation given to the participants by their physicians, including diet, physical activity, medication and glycemic control instructions.
Eligibility Criteria
You may qualify if:
- BMI ≥ 25;
- Age ≥ 18;
- Diagnosis of type 2 diabetes;
- Fluent English or Italian.
You may not qualify if:
- Inability to provide informed consent to participate in the study for any reason, including cognitive impairment and psychiatric illness;
- Presence of any medical condition that would make participation in the study difficult and/or unsafe;
- Presence of any medical condition associated with unintentional weight loss or gain;
- Presence of untreated, severe and/or recently diagnosed (≤ 6 months) mental illness and/or presence of a severe personality disorder;
- History of eating disorders and/or substance abuse;
- Use of drugs for weight loss;
- Participation in another weight loss program or in any other trial;
- Participation in an individual or group psychological intervention;
- Weight loss surgery within the year;
- Pregnant or are planning to become pregnant within the year
- Inability to control meal contents (e.g. institutionalized patients).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chiara Rafanellilead
Study Sites (2)
Struttura Semplice di Endocrinologia e Metabolismo, Ospedale Oglio Po
Casalmaggiore, Cremona, 26041, Italy
Servizio Endocrinologia e Diabetologia, Ospedale Bufalini
Cesena, Forlì-Cesena, 47521, Italy
Related Publications (7)
Hill JO. Can a small-changes approach help address the obesity epidemic? A report of the Joint Task Force of the American Society for Nutrition, Institute of Food Technologists, and International Food Information Council. Am J Clin Nutr. 2009 Feb;89(2):477-84. doi: 10.3945/ajcn.2008.26566. Epub 2008 Dec 16.
PMID: 19088151BACKGROUNDPhillips-Caesar EG, Winston G, Peterson JC, Wansink B, Devine CM, Kanna B, Michelin W, Wethington E, Wells M, Hollenberg J, Charlson ME. Small Changes and Lasting Effects (SCALE) Trial: the formation of a weight loss behavioral intervention using EVOLVE. Contemp Clin Trials. 2015 Mar;41:118-28. doi: 10.1016/j.cct.2015.01.003. Epub 2015 Jan 26.
PMID: 25633208BACKGROUNDPhillips EG, Wells MT, Winston G, Ramos R, Devine CM, Wethington E, Peterson JC, Wansink B, Charlson M. Innovative approaches to weight loss in a high-risk population: The small changes and lasting effects (SCALE) trial. Obesity (Silver Spring). 2017 May;25(5):833-841. doi: 10.1002/oby.21780. Epub 2017 Apr 5.
PMID: 28382755BACKGROUNDGeiker NRW, Astrup A, Hjorth MF, Sjodin A, Pijls L, Markus CR. Does stress influence sleep patterns, food intake, weight gain, abdominal obesity and weight loss interventions and vice versa? Obes Rev. 2018 Jan;19(1):81-97. doi: 10.1111/obr.12603. Epub 2017 Aug 28.
PMID: 28849612BACKGROUNDFava GA. Well-Being Therapy: Current Indications and Emerging Perspectives. Psychother Psychosom. 2016;85(3):136-45. doi: 10.1159/000444114. Epub 2016 Apr 5. No abstract available.
PMID: 27043240BACKGROUNDRyff CD. Psychological well-being revisited: advances in the science and practice of eudaimonia. Psychother Psychosom. 2014;83(1):10-28. doi: 10.1159/000353263. Epub 2013 Nov 19.
PMID: 24281296BACKGROUNDBenasi G, Gostoli S, Zhu B, Offidani E, Artin MG, Gagliardi L, Rignanese G, Sassi G, Fava GA, Rafanelli C. Well-Being Therapy and Lifestyle Intervention in Type 2 Diabetes: A Pilot Randomized Controlled Trial. Psychosom Med. 2022 Nov-Dec 01;84(9):1041-1049. doi: 10.1097/PSY.0000000000001115. Epub 2022 Aug 2.
PMID: 36346956DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chiara Rafanelli, MD, PhD
University of Bologna
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- A researcher adequately trained in the administration of questionnaires and interviews, and blinded to the experimental allocation of patients, will carry out all the evaluations.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor of Clinical Psychology
Study Record Dates
First Submitted
July 11, 2018
First Posted
August 1, 2018
Study Start
March 27, 2018
Primary Completion
November 18, 2020
Study Completion
November 18, 2020
Last Updated
March 12, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share